Subject(s)
Ill-Housed Persons , Social Work/organization & administration , Surveys and Questionnaires/standards , United States Dept. of Health and Human Services/organization & administration , Age Factors , Housing/supply & distribution , Humans , Mental Disorders/epidemiology , Racial Groups , Risk Assessment , Risk Factors , Social Work/standards , Time Factors , United States , United States Dept. of Health and Human Services/standardsSubject(s)
COVID-19/therapy , Critical Care , Pandemics , Telemedicine/organization & administration , Biomedical Technology , Disaster Planning , Disasters , Humans , Military Personnel , Patient Care Team/organization & administration , Public-Private Sector Partnerships/organization & administration , Referral and Consultation , SARS-CoV-2 , United States , United States Dept. of Health and Human Services/organization & administrationABSTRACT
Dr. Kara Odom Walker is Secretary of the Delaware Department of Health and Social Services (DHHS). Trained as a family physician, with advanced degrees in public health and health services research, Dr. Walker has worked for numerous organizations to advocate for health equity and care for underserved populations. As Delaware DHHS Secretary, she oversees a department with an annual budget of over $2 billion, responsible for health and social services administration.
Subject(s)
Public Health/economics , Public Health/standards , State Government , United States Dept. of Health and Human Services/trends , Delaware , Humans , Public Health/trends , United States , United States Dept. of Health and Human Services/organization & administrationABSTRACT
The US Department of Health and Human Services (HHS) has developed and is implementing an agency-wide Digital Communications Strategy. A robust strategy to coordinate digital communications is vital at times of crisis, such as the COVID-19 pandemic - and will be needed as part of an effective HHS campaign to motivate individuals who are hesitant to accept coronavirus vaccines. Using science-based principles of systems change, a four-phase approach was developed in alignment with the 21st Century Integrated Digital Experience Act (IDEA). Phase I involved announcing a plan for creating and implementing the HHS Digital Communications Strategy, including support for it from the HHS Secretary. Phase II involved gathering information and stakeholder support, with an interview research study as the central component for providing input and encouraging stakeholder engagement. Phase III focused on building the Strategy through an iterative process. Phase IV, which is ongoing, concentrates on implementing the Strategy, measuring the impact of digital communications and supporting the budget required to modernize Federal digital communications approaches to meet the American public's needs. Learnings from the work so far are consistent with those from prior HHS systems change efforts in communications - and are helping to improve the Strategy in real time.
Subject(s)
COVID-19/prevention & control , Health Communication/methods , United States Dept. of Health and Human Services/organization & administration , COVID-19/epidemiology , COVID-19/psychology , Humans , Program Development , United StatesABSTRACT
This article describes the origins and drafting of the Belmont Report by members of the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research.
Subject(s)
Biomedical Research/ethics , Ethics, Research/history , Human Experimentation/ethics , United States Dept. of Health and Human Services/organization & administration , Biomedical Research/history , History, 20th Century , History, 21st Century , Human Experimentation/history , Humans , Informed Consent/standards , National Institutes of Health (U.S.)/standards , Politics , United States , United States Dept. of Health and Human Services/standardsABSTRACT
The Belmont Report has provided a useful and virtually universal framework for protecting human subjects from research abuses. However, it provides little to no guidance on the substance of human research. In an environment where major decisions concerning health-care access, funding, and regulation hinge on human research, this omission leaves downstream users of human research virtually unprotected and with few tools or frameworks to protect against a variety of practices that compromise the social value of human research. This essay advocates for the addition of a fourth principle to the Belmont three: "scientific integrity." Such a principle would seek to train human research on important social objectives while maximizing the accessibility, credibility, and generalizability of findings.
Subject(s)
Biomedical Research/ethics , Ethics, Research , Human Experimentation/ethics , United States Dept. of Health and Human Services/organization & administration , Community Participation , Humans , Informed Consent/standards , Politics , Research Support as Topic/ethics , Research Support as Topic/standards , Scientific Misconduct/ethics , United States , United States Dept. of Health and Human Services/standardsSubject(s)
Epidemics/prevention & control , Epidemics/statistics & numerical data , HIV Infections/epidemiology , HIV Infections/prevention & control , United States Dept. of Health and Human Services/organization & administration , AIDS Vaccines/administration & dosage , Acquired Immunodeficiency Syndrome/prevention & control , Anti-Retroviral Agents/therapeutic use , Case Management/organization & administration , Diagnostic Techniques and Procedures , Financing, Government , HIV Infections/diagnosis , HIV Infections/drug therapy , Humans , Leadership , Needle-Exchange Programs/organization & administration , Organizational Objectives , Pre-Exposure Prophylaxis/methods , United States/epidemiology , United States Dept. of Health and Human Services/economicsSubject(s)
Epidemics/prevention & control , HIV Infections/epidemiology , HIV Infections/prevention & control , Acquired Immunodeficiency Syndrome/prevention & control , Anti-Retroviral Agents/therapeutic use , Diagnostic Techniques and Procedures , HIV Infections/diagnosis , Health Policy , Health Services Accessibility/organization & administration , Humans , Leadership , Medical Assistance/organization & administration , Poverty , Pre-Exposure Prophylaxis/methods , Safety-net Providers/organization & administration , Sexually Transmitted Diseases/epidemiology , Sexually Transmitted Diseases/therapy , Socioeconomic Factors , United States/epidemiology , United States Dept. of Health and Human Services/organization & administrationABSTRACT
In his State of the Union Address on February 5, 2019, President Donald J. Trump announced his administration's goal to end the domestic HIV epidemic. Following the announcement of the Ending the HIV Epidemic: A Plan for America initiative, the president proposed $291 million in new funding for the fiscal year 2020 Department of Health and Human Services (HHS) budget to implement a new initiative to reduce the number of new HIV infections by 75% in the next five years (2025) and by 90% in the next 10 years (2030). This is in addition to the $20 billion the US government already spends each year, domestically, for HIV prevention and care.With this initiative, HHS recognizes that the time to end the HIV epidemic is now: we have the right data, the right biomedical and behavioral tools, and the right leadership. With the new resources, the goal is achievable.This article outlines how this initiative will be accomplished through the implementation of four fundamental strategies that will be tailored by local communities on the basis of their own needs and strengths.
Subject(s)
Epidemics/prevention & control , Epidemics/statistics & numerical data , HIV Infections/epidemiology , HIV Infections/prevention & control , United States Dept. of Health and Human Services/organization & administration , AIDS Vaccines/administration & dosage , Acquired Immunodeficiency Syndrome/prevention & control , Anti-Retroviral Agents/therapeutic use , Case Management/organization & administration , Diagnostic Techniques and Procedures , Financing, Government , HIV Infections/diagnosis , HIV Infections/drug therapy , Humans , Leadership , Needle-Exchange Programs/organization & administration , Organizational Objectives , Pre-Exposure Prophylaxis/methods , United States/epidemiology , United States Dept. of Health and Human Services/economicsABSTRACT
Seven former commissioners of the Food and Drug Administration (FDA) from both sides of the political aisle recommend that the FDA be moved out of the Department of Health and Human Services and reconfigured as an independent federal agency. We believe that such a reengineering would promote reliance on consistent science-based regulation and ensure that the American public has access to the best that science and industry can offer.
Subject(s)
Biomedical Research , Decision Making , United States Dept. of Health and Human Services/organization & administration , United States Food and Drug Administration/organization & administration , Humans , United States , United States Food and Drug Administration/legislation & jurisprudenceSubject(s)
Centers for Disease Control and Prevention, U.S./organization & administration , HIV Infections/prevention & control , Interinstitutional Relations , Minority Groups , United States Dept. of Health and Human Services/organization & administration , Cooperative Behavior , HIV Infections/diagnosis , HIV Infections/therapy , Health Services Accessibility/organization & administration , Health Status Disparities , Humans , United StatesSubject(s)
Centers for Disease Control and Prevention, U.S./organization & administration , HIV Infections/prevention & control , Minority Groups , Social Determinants of Health/ethnology , United States Dept. of Health and Human Services/organization & administration , HIV Infections/diagnosis , HIV Infections/therapy , Health Status Disparities , Humans , Interinstitutional Relations , United StatesSubject(s)
Centers for Disease Control and Prevention, U.S./organization & administration , HIV Infections/prevention & control , Interinstitutional Relations , Minority Groups , United States Dept. of Health and Human Services/organization & administration , Cooperative Behavior , HIV Infections/diagnosis , HIV Infections/therapy , Health Services Accessibility/organization & administration , Health Status Disparities , Humans , Patient Navigation/organization & administration , Program Evaluation , Public Health Surveillance/methods , Social Stigma , United StatesSubject(s)
HIV Infections/prevention & control , Health Services Accessibility/organization & administration , Interinstitutional Relations , Minority Groups , United States Dept. of Health and Human Services/organization & administration , Acquired Immunodeficiency Syndrome/prevention & control , Centers for Disease Control and Prevention, U.S. , Continuity of Patient Care/organization & administration , Goals , Health Status Disparities , Humans , Patient Navigation/organization & administration , Research/organization & administration , United StatesSubject(s)
HIV Infections/epidemiology , HIV Infections/prevention & control , Minority Groups , United States Dept. of Health and Human Services/organization & administration , Acquired Immunodeficiency Syndrome/epidemiology , Acquired Immunodeficiency Syndrome/prevention & control , Age Factors , Capacity Building/organization & administration , Financing, Government/organization & administration , HIV Infections/ethnology , Health Status Disparities , Humans , Sex Factors , Sexuality , Socioeconomic Factors , United States , United States Dept. of Health and Human Services/economicsSubject(s)
Conscience , Health Personnel/ethics , Refusal to Treat/legislation & jurisprudence , Religion and Medicine , United States Dept. of Health and Human Services/organization & administration , Abortion, Legal , Civil Rights , Female , Health Personnel/psychology , Humans , Pregnancy , Refusal to Treat/ethics , United StatesABSTRACT
Having been a significance source of the renewed interested in the adolescent period, developmental neuroscience now needs to build upon its achievements to date and expand in several areas in order to broaden its impact upon the field. Addressing both typical and atypical development, examining the interaction between brain development and the social environment, studying change over time, and including attention to population diversity can help to produce a truly integrative science of adolescent development. The papers in the special section provide nice examples of how developmental neuroscience can make such expansions and continue to contribute to the field in the years to come.
Subject(s)
Adolescent Development/physiology , Brain/growth & development , Neurosciences/methods , Adolescent , Adult , Brain/diagnostic imaging , Brain/physiology , Child , Cognition/physiology , Cultural Diversity , Humans , Nerve Net , Neuroimaging/methods , Population Dynamics/trends , Social Environment , United States/epidemiology , United States Dept. of Health and Human Services/organization & administration , Young AdultABSTRACT
CONTEXT: As the US health care system continues to undergo dynamic change, the increased alignment between health care quality and payment has provided new opportunities for public health and health care sectors to work together. PROGRAM: The Centers for Disease Control and Prevention's 6|18 Initiative accelerates cross-sector collaboration between public health and health care purchasers, payers, and providers and highlights 6 high-burden conditions and 18 associated interventions with evidence of cost reduction/neutrality and improved health outcomes. This evidence can inform payment, utilization, and quality of prevention and control interventions. IMPLEMENTATION: The Centers for Disease Control and Prevention focused initially on public payer health insurance interventions for asthma control, unintended pregnancy prevention, and tobacco cessation. Nine state Medicaid and public health agency teams-in Colorado, Georgia, Louisiana, Massachusetts, Michigan, Minnesota, New York, Rhode Island, and South Carolina-participated in the initiative because they had previously prioritized the health condition(s) and specific intervention(s) and had secured state-level leadership support for state agency collaboration. The Centers for Disease Control and Prevention, the Centers for Medicare & Medicaid Services, the Center for Health Care Strategies, the Robert Wood Johnson Foundation, and other partners supported state implementation and dissemination of early lessons learned. EVALUATION: The Centers for Disease Control and Prevention conducted exploratory interviews to guide improvement of the 6|18 Initiative and to understand facilitators, barriers, and complementary roles played by each sector. Monthly technical assistance calls conducted with state teams documented collaborative activities between state Medicaid agencies and health departments and state processes to increase coverage and utilization. DISCUSSION: The 6|18 Initiative is strengthening partnerships between state health departments and Medicaid agencies and contributing to state progress in helping improve Medicaid coverage and utilization of effective prevention and control interventions. This initiative highlights early successes for others interested in strengthening collaboration between state agencies and between public and private sectors to improve payment, utilization, and quality of evidence-based interventions.